Action(s) taken or orders passed

14th July, 2026 Corporate Relationship Department The Manager - Listing M/s. BSE Limited M/s. National Stock Exchange of India Ltd Mumbai 400001 Bandra (E) Mumbai 400051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir/Madam, Sub:- Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the disclosure as per format provided in SEBI Master Circular dated 30th January 2026: Sl. Particulars Information a) Name of the authority Assistant Commissioner (ST)(FAC), Tenali Circle, Tenali, Andhra Pradesh b) Nature and details of the action(s) Order passed under the APGST & CGST Act, 2017 for the taken, initiated or order(s) passed audit conducted for the period 1st April 2020 to 17th December 2024, raising a tax demand of Rs. 21,34,729/-, interest of Rs 17,17,806/- and penalty of Rs.21,34,729/- We are currently evaluating the matter and will take the appropriate course of action. c) Date of receipt of direction or order, Order dated 13th July 2026 and received on 13th July 2026 including any ad-interim or interim orders, or any other communication from the authority d) Details of Lower amount reported under the Reverse Charge violation(s)/contraventions(s) Mechanism (RCM) in GSTR 3B. committed or alleged to be committed e) Impact on financial, operation or other There is no material impact on financial, operational and activities of the listed entity, other activities of the Company. quantifiable in monetary terms to the extent possible This is for your information and records. Thanking you, Yours faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer